Moderna, Inc.
做多

MRNA after the published data

115
MRNA announced Phase 3 trial results late last night emphasizing the need for a booster shot. On Friday the FDA meets to discuss this issue. Lots of free room on the chart if the decision is positive.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。